Global Health Experts Appointed to Judge Aster Guardians Global Nursing Award 2025, to Be Held in Dubai
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Aster DM Healthcare, one of the leading integrated healthcare providers in GCC & India, has announced the distinguished Grand Jury panel for the Aster Guardians Global Nursing Award 2025 to be held in Dubai on May 26, 2025. This esteemed panel includes five leading healthcare and nursing experts: Prof. Sheila Tlou, Co-Chairperson of the Global HIV Prevention Coalition, Botswana, Special Ambassador of the African Leaders Malaria Alliance and Former Minister of Health, Botswana; Prof. James Buchan, Adjunct Professor at the WHO Collaborating Centre, University of Technology, Sydney, and Editor Emeritus of the Human Resources for Health Journal; Dr. Peter Carter, OBE Awardee and Independent Healthcare Consultant, Former CEO Central & Northwest London, NHS and Former CEO of Royal College of Nursing, UK; Dr. Niti Pall, President Elect at International Diabetes Federation, Senior Consultant at AXA EssentiAll, France and Board Chair of Harbr & Managing Director of Health4all Advisory, UK and Mr. Vishal Bali, Executive Chairman of Asia Healthcare Holdings & Senior Advisor, TPG Growth, and General Council Member, Neonates Foundation of India.
Aster has appointed Ernst & Young LLP (EY) to assess the applications, overseeing shortlisting with an independent panel, and presenting finalists to the Grand Jury.
Reflecting on the entries this year, Dr Azad Moopen, Founder Chairman of Aster DM Healthcare, said ' It has been inspiring to observe the evolution of the platform, and its impact on the global nursing community. The remarkable response to the 4th edition, with over 100,000 registrations from 199 countries, underscores the global significance of this initiative. We eagerly anticipate meeting the top 10 finalists, distinguished nurses from around the world, as they compete for the esteemed award and a $250,000 prize."
In the previous edition, Philippine-based Nurse Maria Victoria Juan emerged as the winner for her exceptional contributions in leadership, nursing education and community service.
About Aster DM Healthcare
Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading integrated healthcare provider, with a strong presence across seven countries. Aster is committed to the vision of providing accessible and high-quality healthcare, from primary to quaternary services, with its promise of 'We will treat you well'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Popular Pistachio Cream Linked Salmonella Outbreak In Multiple States
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." It may be a guava summer, but we're all obsessed with pistachios right now. I mean, have you seen the number of pistachio-flavored products popping up at Costco and Trader Joe's? It's all thanks to Dubai chocolate taking over our taste buds. (Seriously, if you haven't jumped on the pistachio train yet, you need to do so ASAP.) Just make sure you stay away from the cream for now... because it might be contaminated. Yep, tragic news incoming: a multistate Salmonella outbreak has been linked to Emek-brand Pistachio Cream. According to the Food and Drug Administration (FDA), this Turkey-based cream brand is tied to the Salmonella outbreak in Minnesota and New Jersey. So far, four cases have been reported, and one person has been hospitalized. Thankfully, no deaths have been reported at this time. The FDA reports that all affected individuals consumed the cream, with three of them confirming they ate it at the same location. To make matters worse, the Minnesota Department of Health notified the FDA that a sample of the Pistachio Cream tested positive for Salmonella. Yikes. While there hasn't been an official recall yet, it's likely the cream is the source of the outbreak and will be pulled from shelves soon. If you've recently purchased Emek-brand Pistachio Cream and are worried it might be contaminated, here's what you need to know: the affected cream has a use-by date of October 19, 2026, and the product code 241019. If you have this cream in your pantry or refrigerator, it's probably best to toss it and stay safe. Be sure to keep an eye out for any official recall announcements. And if you're really craving pistachio (no judgment here), Amazon has some pretty good dupes, if I do say so myself.$14.99 at at at You Might Also Like Insanely Easy Weeknight Dinners To Try This Week 29 Insanely Delicious Vodka Cocktails
Yahoo
10 hours ago
- Yahoo
HSS Study at EULAR 2025 Congress Uses an AI Model to Predict Readmissions of Pregnant Women with Lupus Based on Social Determinants of Health
BARCELONA, Spain, June 14, 2025--(BUSINESS WIRE)--Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting showing that an artificial intelligence (AI)-based model can predict readmissions of pregnant women with lupus by looking at patients' social factors and clinical comorbidities. Systemic lupus erythematosus (SLE), commonly known as lupus, is a chronic autoimmune disease in which the immune system attacks the individual's own healthy tissue, causing pain, inflammation, and eventually damage to various organs. It commonly affects young women, and pregnancy is a particularly vulnerable period for this high-risk population. Although lupus-related medical complications affect pregnancy outcomes, social determinants and economic conditions, known as social determinants of health (SDOH), may also be important in shaping maternal health outcomes. "Pregnant women with lupus have five times higher maternal mortality compared to those without lupus," said Sandhya Shri Kannayiram, MBBS, MD, rheumatology fellow at HSS and principal author of the study. "There is little data on how social factors, including Income, Insurance, housing stability, access to transportation, availability of utilities, and literacy, along with clinical comorbidities, affect pregnancy outcomes in individuals with lupus." To better understand how SDOH impact readmissions for pregnant patients with SLE, the team used ten-year data (from 2011 to 2021) from the National Readmissions Database of the US, encompassing approximately 66,000 hospitalizations in the United States, and counted the number of readmissions within 30 days of discharge during pregnancy and delivery. "We found that approximately 2,500 [pregnant women with lupus] were readmitted to the hospital within 30 days," said Dr. Kannayiram. "We used a supervised 'glass box' machine learning model called the Explainable Boosting Machine (EBM), which helped predict who is likely to return to the hospital within 30 days," said Dr. Kannayiram. She explained that EBM is a form of machine learning with a type of AI that learns from data to make predictions. "It's an AI model that can be trained on the dataset to predict outcomes with transparency and accuracy compared to traditional statistical models," she added. The team specifically examined the major social determinants from the database that may influence readmissions during pregnancy in SLE, including Income and insurance status (public, private, or self-pay). Dr. Kannayiram explained that the results obtained showed patients living in lower-income neighborhoods were nearly twice as likely to be readmitted compared to those from wealthier areas, and those with Medicaid or Medicare insurance were more likely to be readmitted within 30 days. Patients discharged to locations other than home, such as rehabilitation facilities or nursing homes, were also more likely to return. However, they also found unexpected correlations. "We found that the size of hospitals was highly related to readmissions, rather than the location, such as cities or rural areas," said Dr. Kannayiram, with large hospitals being the ones with more readmissions. Additionally, unlike most pregnancy studies, where older mothers are usually at higher risk, this study found that younger women with lupus were more likely to be readmitted. Dr. Kannayiram said that this result may be related to severe lupus in younger individuals since about half of the readmitted patients had Medicare coverage, which may suggest a high prevalence of disability or kidney disease within that younger population. By using the predictive AI model, the team also discovered that income and insurance status were among the top five predictors of 30-day readmission during pregnancy and delivery-related hospitalizations, explained Bella Mehta, MBBS, MS, MD, rheumatologist at HSS and lead author of the study. She noted that these results could inform targeted interventions, such as policy actions to advocate for improved Medicaid and Medicare coverage, as well as post-discharge care coordination. "Integrating SDOH screening into prenatal care for SLE patients, and incorporating a multidisciplinary team of social workers, could reduce preventable readmissions and improve maternal outcomes," added Dr. Mehta. According to Dr. Mehta, in future studies, the team plans to analyze in detail how individual-level social factors, such as housing instability, food insecurity, education, mental health, transportation access, and patient demographics, interact with clinical comorbidities to determine pregnancy outcomes for women with SLE. "This study underscores the vital intersection between clinical care and structural inequality," said Dr. Mehta. "The lupus community and broader maternal health initiatives must not only consider disease management but also address the social factors that influence outcomes." Poster details Title: Predictors of 30-Day Readmissions in Pregnant Patients with Systemic Lupus Erythematosus: The Role of Social Determinants of HealthAuthors: Sandhya Shri Kannayiram, Yiyuan Wu, Lisa Sammaritano, Michael Lockshin, Rich Caruna, D. Ware Branch, Jane E. Salmon, Bella n°: 2325Presentation: June 14th, 2025. 10:00 AM CEST About HSS HSS is the world's leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 15th consecutive year), No. 3 in rheumatology by U.S. News & World Report (2024-2025), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report "Best Children's Hospitals" list (2024-2025). In a survey of medical professionals in more than 20 countries by Newsweek, HSS is ranked world #1 in orthopedics for a fifth consecutive year (2025). Founded in 1863, the Hospital has the lowest readmission rates in the nation for orthopedics, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center five consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnose, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Innovation Institute works to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. View source version on Contacts Tracy Hickenbottom/Rachael Rennich212-606-1197mediarelations@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 hours ago
- Yahoo
Jewish Family Services receives $400K for opioid use support program
Niagara County and New York State have awarded Jewish Family Services $400,000 to provide services to those impacted by opioid use. The county awarded a $350,000 two-year grant to JFS for a comprehensive career support and care management recovery program at its Niagara Falls office. The state Office of Faith and Nonprofit Development Services awarded $50,000 to develop a community resource room for families served by care coordination and health home programs and for new American families. Both plan to start later this year. 'From addressing behavioral health and wellness needs to help prevent relapse and post-lasting recovery, to providing a safe space for families to work toward securing self-sustainability, JFS staff is committed to empowering individuals with the resources needed for long-term success,' said Jewish Family Services CEO Molly Carr in a statement. Around 12% of clients enrolled in JFS's Niagara County-based health home program have suffered from opioid use disorder, substance abuse, and other mental health conditions. It helped between 250 and 300 clients in the county in 2023. 'While those in recovery are faced with many challenges, one of the biggest can be getting back into the workforce,' said County Legislator Jesse Gooch, chair of the Community Services Committee. 'The JFS program has a focus on employment services, something that is sorely needed, which is why we were happy to award them grant funding through the opioid settlement fund.' The community resource room will have laptops, internet access, printers, scanners, and noise-cancelling headphones on hand. Case managers will be available by appointment for job application help and technology and interpretation services. JFS opened its Niagara Falls office on Third Street last August, with case workers there working on career services and refugee resettlement programming. It has operated in Buffalo since 1862, starting Niagara County services in 2021. It was one of many area nonprofits that had to cut positions earlier this year after the Trump administration froze funds meant for agencies that help new refugee arrivals. It partnered with four other Buffalo agencies to raise $1.5 million in February and March to cover funding shortfalls.
